Related Experiment Videos
Concentration of azithromycin in human prostatic tissue.
Summary
Azithromycin concentrates highly in prostate tissue, reaching levels significantly above plasma concentrations 14 hours after oral dosing. This antibiotic demonstrates slow elimination from the prostate, with substantial amounts remaining even after 137 hours.
Area of Science:
- Pharmacokinetics and Drug Distribution
- Urology
- Infectious Diseases
Background:
- Prostate infections are challenging to treat due to poor drug penetration.
- Understanding antibiotic concentrations in prostatic tissue is crucial for effective treatment regimens.
Purpose of the Study:
- To quantify azithromycin concentrations in human prostatic tissue.
- To compare prostatic tissue concentrations with plasma levels.
- To determine the elimination half-life of azithromycin in prostatic tissue.
Main Methods:
- Prostatic tissue samples were collected from 36 patients across two study sites.
- Azithromycin levels were measured using High-Performance Liquid Chromatography (HPLC) or bioassay.
- Pharmacokinetic parameters, including tissue half-life, were calculated.
Main Results:
- Mean azithromycin concentration in prostatic tissue was 2.54 µg/ml at 14 hours post-dosing (500 mg oral).
- Prostatic tissue concentrations were significantly higher than plasma concentrations (≤0.1 µg/ml).
- Azithromycin exhibited slow elimination from prostatic tissue with a half-life of approximately 60 hours, with 0.62 µg/ml remaining at 137 hours.
Conclusions:
- Oral azithromycin achieves high and sustained concentrations in human prostatic tissue.
- The pharmacokinetic profile suggests azithromycin may be effective for treating prostatic infections.
- Further clinical studies are warranted to confirm therapeutic efficacy.